199 related articles for article (PubMed ID: 2538826)
21. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.
Matsuda S; Gidlund M; Chiodi F; Cafaro A; Nygren A; Morein B; Nilsson K; Fenyö EM; Wigzell H
Scand J Immunol; 1989 Oct; 30(4):425-34. PubMed ID: 2554488
[TBL] [Abstract][Full Text] [Related]
22. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
23. Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents.
Pincus SH; Wehrly K; Chesebro B
Biotechniques; 1991 Mar; 10(3):336-42. PubMed ID: 2064772
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a monoclonal antibody specific for the HIV-1 precursor glycoprotein.
Krust B; Laurent AG; Le Guern A; Jeannequin O; Montagnier L; Hovanessian AG
AIDS; 1988 Feb; 2(1):17-24. PubMed ID: 2833905
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus cell entry: new insights into the fusion mechanism.
Burny A; Bex F; Brasseur R; Khim MC; Delchambre M; Horth M; Verdin E
J Acquir Immune Defic Syndr (1988); 1988; 1(6):579-82. PubMed ID: 2852244
[No Abstract] [Full Text] [Related]
26. Improved antigenicity of the HIV env protein by cleavage site removal.
Kieny MP; Lathe R; Rivière Y; Dott K; Schmitt D; Girard M; Montagnier L; Lecocq J
Protein Eng; 1988 Sep; 2(3):219-25. PubMed ID: 3237686
[TBL] [Abstract][Full Text] [Related]
27. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
[TBL] [Abstract][Full Text] [Related]
28. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.
Wahl LM; Corcoran ML; Pyle SW; Arthur LO; Harel-Bellan A; Farrar WL
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):621-5. PubMed ID: 2536171
[TBL] [Abstract][Full Text] [Related]
30. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.
Dewar RL; Vasudevachari MB; Natarajan V; Salzman NP
J Virol; 1989 Jun; 63(6):2452-6. PubMed ID: 2542563
[TBL] [Abstract][Full Text] [Related]
31. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127
[TBL] [Abstract][Full Text] [Related]
32. Production of human monoclonal antibodies against HIV-1 peptides.
Bongertz V; Wigzell H; Rossi P
Braz J Med Biol Res; 1991; 24(8):815-8. PubMed ID: 1797270
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
[TBL] [Abstract][Full Text] [Related]
34. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
[TBL] [Abstract][Full Text] [Related]
35. Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I.
Teeuwsen VJ; Siebelink KH; Crush-Stanton S; Swerdlow B; Schalken JJ; Goudsmit J; van de Akker R; Stukart MJ; Uytdehaag FG; Osterhaus AD
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):381-92. PubMed ID: 1692724
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
[TBL] [Abstract][Full Text] [Related]
37. In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection.
Pincus SH; Fang H; Wilkinson RA; Marcotte TK; Robinson JE; Olson WC
J Immunol; 2003 Feb; 170(4):2236-41. PubMed ID: 12574398
[TBL] [Abstract][Full Text] [Related]
38. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein.
Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J
J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562
[TBL] [Abstract][Full Text] [Related]
40. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
Neurath AR; Strick N; Lee ES
J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
